On Feb. 7, biotech company Affymetrix
- Revenues were down by 6.5%, primarily because of a 15% decrease in product sales.
- Gross margins were significantly affected by forward pricing of the company's two-chip 500K mapping product.
- EPS was down by 70% on the drop in sales and falling margins.
(Figures in millions, except per-share data)
Income Statement Highlights
Q4 2006 |
Q4 2005 |
Change |
|
---|---|---|---|
Sales |
$104.2 |
$111.5 |
(6.5%) |
Net Profit |
$8.7 |
$30.6 |
(71.6%) |
EPS |
$0.13 |
$0.43 |
(69.8%) |
Diluted Shares |
71.9 |
72.3 |
(0.5%) |
Get back to basics with a look at the income statement.
Margin Checkup
Q4 2006 |
Q4 2005 |
Change* |
|
---|---|---|---|
Gross Margin |
62.0% |
71.8% |
(9.8) |
Operating Margin |
10.1% |
19.5% |
(9.4) |
Net Margin |
8.3% |
27.5% |
(19.1) |
Margins are the earnings engine. See how they work.
Balance Sheet Highlights
Assets |
Q4 2006 |
Q4 2005 |
Change |
---|---|---|---|
Cash + ST Invest. |
$237.2 |
$284.9 |
(16.8%) |
Accounts Rec |
$77.8 |
$97.1 |
(19.8%) |
Inventory |
$46.5 |
$36.0 |
29.3% |
Liabilities |
Q4 2006 |
Q4 2005 |
Change |
---|---|---|---|
Accounts Payable |
$62.9 |
$71.6 |
(12.1%) |
Long-Term Debt |
$120.0 |
$120.0 |
0.0% |
Learn the ways of the balance sheet.
Cash Flow Highlights
A statement of cash flows was not provided.
Find out why Fools always follow the money.
Related Companies:
-
Bio-Rad Laboratories
(AMEX:BIO) -
PDL Biopharma
(NASDAQ:PDLI) -
Illumina
(NASDAQ:ILMN) -
Human Genome Sciences
(NASDAQ:HGSI) -
Myriad Genetics
(NASDAQ:MYGN)
Related Foolishness:
Affymetrix, PDL Biopharma, and Myriad Genetics are all Motley Fool Rule Breakers recommendations. To see why, you can take a 30-day free trial of our growth-stock service.
Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so check Fool.com for more of our in-depth discussion of what the numbers mean. This data has been provided by Netscribes. To provide feedback on this article, please click on the "feedback" button below.